The combination drug didn’t help patients any more than chemotherapy, but Merck will continue the trial to test it together with chemo.
News Ticker
- [ March 31, 2023 ] Biostatistician II – Hospital for Special Surgery – New York, NY Jobs
- [ March 31, 2023 ] IP/Life Sciences Associate – Greenberg Traurig – Florham Park, NJ Jobs
- [ March 31, 2023 ] IP/Life Sciences Associate – Greenberg Traurig – New York, NY Jobs
- [ March 31, 2023 ] IP/Life Sciences Patent Agent – Greenberg Traurig – New York, NY Jobs
- [ March 31, 2023 ] Fujirebio further extends its fully automated blood-based biomarker portfolio with the fully automated Lumipulse® G ApoE4 and Lumipulse® G Pan-ApoE assays for Research Use Only News
Copyright © 2023 Biotech Networks, LLC
Be the first to comment